Company news

AbbVie Inc. news in 2025

AbbVie Inc.'s news releases, calls and decks from 2025, newest first.

View company

Refresh Releases First of its Kind Eye Drop for Dry Eyes

July 11, 2025

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

July 10, 2025

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

July 10, 2025

AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology

June 30, 2025

U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance

June 30, 2025

AbbVie to Host Second-Quarter 2025 Earnings Conference Call

June 30, 2025

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

January 11, 2025

← Newer news releases

Calls in 2025

Decks in 2025